In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Epigenomics raises €33mm through private placement

Executive Summary

Epigenomics AG (molecular diagnostics for cancer) raised €33mm ($45mm) through the oversubscribed private sale of 14.7mm shares at €2.25 each (a 15% discount). Existing investor Abingworth was one of the participants, and as a result of its purchase is now the company's largest shareholder. Other returning and new buyers also took part.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies